CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.

In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...

The Federal Trade Commission on Friday sued prescription-drug middlemen owned by CVS Health Corp., Cigna Group and UnitedHealth Group Inc., alleging that they artificially pumped up prices of insulin ...

The Face Shop, a K-Beauty skin care brand, is broadening its distribution following the news that it will be available in ...

We recently compiled a list of the 10 Best Fortune 500 Stocks To Buy Now. In this article, we are going to take a look at ...

If you're a CVS shopper you're gonna want to check out the deals we've found this week! CVS Deals | Check Out The List and ...

CVS trades below 9x forward PE, indicating it’s priced for further deterioration, but historically and relatively cheap vs.